Article
The common neoantigens in colorectal cancer are predicted and validated to be presented or immunogenic
2019-06-26
Abstract excerpt
<h4>ABSTRACT</h4> Colorectal cancer (CRC) is a malignant cancer with high incidence and mortality in the world, as the result of the traditional treatments. Immunotherapy targeting neoantigens can induce durable tumor regression in cancer patients, but is almost limited to individual treatment, resulting from the unique neoantigens. Many shared oncogenic mutations are detected, but whether the common neoantigens...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 616470a0-4f51-59b7-8393-b9da832ceb19
- DOI
- 10.1101/682617
